Rossby Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$441K Sell
2,816
-85
-3% -$12.7K 0.08% 226
2026
Q1
$450K Buy
2,901
+181
+7% +$27.7K 0.09% 201
2025
Q4
$375K Sell
2,720
-3
-0.1% -$393 0.12% 156
2025
Q3
$359K Buy
2,723
+59
+2% +$7.2K 0.12% 170
2025
Q2
$322K Buy
2,664
+99
+4% +$11.2K 0.12% 175
2025
Q1
$288K Buy
+2,565
New +$273K 0.12% 171

Other funds holding NVS

Rossby Financial's NVS Position: Q2 2026 in Review

Rossby Financial reduced its Novartis (NVS) stake by 2.9% in Q2 2026, selling an estimated $12.7K and leaving 2,816 shares worth $441K. The position accounts for 0.08% of the portfolio, ranked #226.

Rossby Financial first reported a position in NVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $450K in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Rossby Financial held 2,816 shares of Novartis worth $441K as of Q2 2026.
  • Rossby Financial sold 85 Novartis shares in Q2 2026, an estimated $12.7K.
  • Novartis made up 0.08% of Rossby Financial's portfolio in Q2 2026, its #226 holding.
  • Rossby Financial first reported a position in Novartis in Q1 2025 and has held it in 6 quarters since.
  • Rossby Financial's Novartis position peaked at $450K in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.